COMMUNIQUÉS West-GlobeNewswire

VALNEVA : Déclaration d'actions et de droits de vote Mars 2018
06/04/2018
VALNEVA Déclaration d'actions et de droits de vote - MARS 2018 Dénomination sociale : VALNEVA Adresse du siège social : World Trade Center Lyon - Tour Oxygène, 10-12 Boulevard Marius Vivier Merle, 69003 Lyon Marché [...]
MDxHealth Shareholder Transparency Declaration
06/04/2018
Press release Regulated information 6 April 2018, 5.45 p.m. CET MDxHealth Shareholder Transparency Declaration HERSTAL, BELGIUM and IRVINE, CA - April 6, 2018 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" or the [...]
MDxHealth: Déclaration de Transparence d'un Actionnaire
06/04/2018
C ommuniqué de presse Information réglementée 6 avril 2018, 17h45 HEC MDxHealth: Déclaration de Transparence d'un Actionnaire IRVINE, CA, et HERSTAL (BELGIQUE) - le 6 avril 2018 - MDxHealth SA (Euronext Brussels: MDXH [...]
IBA SA : 2018 AGE - AGO CONVENING NOTICE
06/04/2018
Cher Actionnaire, Conc e r n e : Assemblée Générale Extraordinaire du 9 mai 2018 à 9h30 et Assemblée Générale Ordinaire et Spéciale du 9 mai 2018 à 10h00 Nous avons l'honneur de vous convoquer à une Assemblée Générale [...]
Teligent, Inc. Announces FDA Approval of Ciclopirox Shampoo, 1%
06/04/2018
BUENA, N.J., April 06, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
Summit Therapeutics plc : Block listing Interim Review
06/04/2018
BLOCK LISTING SIX MONTHLY RETURN (Note: Italicised terms have the same meaning as given in the Listing Rules.) Date: 6 April 2018 Name of applicant : Summit Therapeutics plc Name of scheme: 2005 EMI Scheme Period of [...]
EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437 in Anterior Uveitis
06/04/2018
Top line Data expected in Q3 2018 WALTHAM, Mass., April 06, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), today announced completion of patient enrollment for the [...]
BioSig Technologies to Present at the MicroCap Conference
06/04/2018
Santa Monica, CA, April 06, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
Tyme and JAF Announce Sarcoma Treatment Collaboration
06/04/2018
NEW YORK, April 06, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ), a clinical-stage oncology company, today announced that it is collaborating with The Joseph Ahmed Foundation (“JAF”) to provide [...]
Adaptimmune to Present Two Posters at the Upcoming American Association for Cancer Research (AACR) Annual Meeting
06/04/2018
PHILADELPHIA, Pa. and OXFORD, U.K., April 06, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: ADAP ), a leader in T-cell therapy to treat cancer, will present two posters summarizing preclinical research [...]
BioCorRx Provides Business Update for the Full Year Ended 2017
06/04/2018
ANAHEIM, CA, April 06, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today provided a business [...]
Aino Health AB (publ): Publication of annual report postponed
06/04/2018
April 6, 2018 Aino Health AB (publ) postpones the publication of the annual report for 2017 until May 9, 2018.The primely release date was April 10, 2018. The reason for the postponement is that the annual report will [...]
Aclaris Therapeutics Partners with Cipher Pharmaceuticals to seek regulatory approval and commercialize A-101 40% topical solution for the treatment of raised seborrheic keratoses in Canada
06/04/2018
The agreement will expand the availability of the first and only U.S. FDA-approved prescription product for the treatment of raised seborrheic keratoses (SKs) WAYNE, Pa., April 06, 2018 (GLOBE NEWSWIRE) -- Aclaris [...]
Shire plc : Rule 2.9 Announcement
06/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 6 April 2018 Shire [...]
Notice convening the Annual General Meeting of NeuroSearch A/S
06/04/2018
Company announcement 6 April 2018 Pursuant to Articles 8 and 9 of the Articles of Association, notice is hereby given of the Annual General Meeting to be held on Monday, 30 April 2018 at 4:00 pm at Kromann Reumert, [...]
MannKind Announces $28.0 Million Registered Direct Offering
06/04/2018
WESTLAKE VILLAGE, Calif., April 06, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD ) today announced the pricing of a registered direct offering of 14,000,000 shares of common stock and warrants to purchase [...]
ThromboGenics announces publication in The Journal of Medicinal Chemistry of preclinical data supporting therapeutic potential of THR-149, a plasma kallikrein inhibitor, in Diabetic Macula Edema
06/04/2018
Press Release Leuven, Belgium, 6 April 2018 - ThromboGenics nv (Euronext Brussels: THR), a biotechnology company developing novel medicines for diabetic eye disease, today announces that positive preclinical data on [...]
The Acarix CADScor®System - on display and in focus at a key scientific symposium at DGK 2018
06/04/2018
Press release Malmö, Sweden April 6, 2018 Introducing an advanced, easy to use, frontline test to rule out Coronary Artery Disease The Acarix CADScor ® System - on display and in focus at a key scientific symposium at [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
06/04/2018
REGULATED INFORMATION GHENT, Belgium, 6 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Pages